These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8093087
1. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies. Kassab JP, Guillot R, Andre J, Claperon N, Bellon G, Feldmann G, Peyroux J, Sternberg M. Biochem Pharmacol; 1994 Aug 30; 48(5):1003-8. PubMed ID: 8093087 [Abstract] [Full Text] [Related]
2. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats. Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR. J Diabet Complications; 1991 Aug 30; 5(4):230-7. PubMed ID: 1779018 [Abstract] [Full Text] [Related]
9. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Beyer-Mears A, Ku L, Cohen MP. Diabetes; 1984 Jun 30; 33(6):604-7. PubMed ID: 6427041 [Abstract] [Full Text] [Related]
10. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Bank N, Mower P, Aynedjian HS, Wilkes BM, Silverman S. Am J Physiol; 1989 Jun 30; 256(6 Pt 2):F1000-6. PubMed ID: 2500028 [Abstract] [Full Text] [Related]
12. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli. Cohen MP, Klepser H, Cua E. Biochim Biophys Acta; 1986 Apr 15; 876(2):226-32. PubMed ID: 3006784 [Abstract] [Full Text] [Related]
13. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus. McCormack AJ, Hak LJ, Finn WF. Ren Fail; 1991 Apr 15; 13(4):267-74. PubMed ID: 1780495 [Abstract] [Full Text] [Related]
14. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats. Sellers DJ, Chess-Williams R. J Auton Pharmacol; 2000 Feb 15; 20(1):15-22. PubMed ID: 11048957 [Abstract] [Full Text] [Related]
15. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat. Sellers DJ, Chess-Williams R. J Pharm Pharmacol; 2000 Jun 15; 52(6):687-94. PubMed ID: 10875546 [Abstract] [Full Text] [Related]
16. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor. Das A, Frank RN, Zhang NL, Samadani E. Exp Eye Res; 1990 Mar 15; 50(3):269-80. PubMed ID: 2108050 [Abstract] [Full Text] [Related]
17. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR, Moriarty RJ, Mayer JH. Diabetes; 1984 May 15; 33(5):470-6. PubMed ID: 6202576 [Abstract] [Full Text] [Related]
18. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor. Beyer-Mears A, Cruz E, Edelist T, Varagiannis E. Pharmacology; 1986 May 15; 32(1):52-60. PubMed ID: 3080763 [Abstract] [Full Text] [Related]
19. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats. Pugliese G, Tilton RG, Speedy A, Oates PJ, Williamson JR. Metabolism; 1994 Apr 15; 43(4):492-500. PubMed ID: 8159110 [Abstract] [Full Text] [Related]
20. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat. Craven PA, DeRubertis FR. Metabolism; 1989 Jul 15; 38(7):649-54. PubMed ID: 2500578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]